목차
1. POLICY CONTEXT 2
2. TRACKING FUNDING CHANGES IN THE GLOBAL HIV RESPONSE 3
2.1. DOMESTIC HIV FINANCING CHANGES . 5
2.2. DOMESTIC FUNDING CHANGES AND PRIORITIES ANNOUNCED IN LIGHT OF GLOBAL DONOR TRANSITIONS IN THE HIV RESPONSE: 6
3. GLOBAL IMPLICATIONS ON HIV AND HEALTH OUTCOMES: MODELLING RESULTS 7
4. IMPLICATIONS OF GLOBAL FUNDING CHANGES ON THE HIV RESPONSE 10
4.1. SPOTLIGHT ON THE EUROPEAN COMMISSION’S CONTRIBUTION TO THE HIV RESPONSE . 11
4.2. SPOTLIGHT ON UK CUTS 12
5. GLOBAL IMPLICATIONS OF FUNDING CHANGES ON RESEARCH AND INNOVATION . 14
FIGURES
FIGURE 1. PERCENT CHANGE OF SELECT DONOR GOVERNMENT FUNDING FOR HIV (BILATERAL & MULTILATERAL- BETWEEN 2019 AND 2024 (USD) 4
FIGURE 2. PERCENT CHANGE OF DAC COUNTRY DISTRIBUTIONS TO UNAIDS BETWEEN 2019 AND 2023 5
FIGURE 3. EUROPEAN COMMISSION HIV FUNDING AMONG DAC BETWEEN 2011-24 12
FIGURE 4. UK BILATERAL AND MULTILATERAL HIV FUNDING BETWEEN 2011-24 (USD IN MILLIONS) 13
FIGURE 5. HOW UK INVESTMENTS IN THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA COULD IMPACT HEALTH OUTCOMES 13
FIGURE 6. GLOBAL DONORS FUNDING HIV RESEARCH IN 2022 14
TABLES
TABLE 1. MODELLING STUDIES OF PROJECTED IMPACTS 7
